A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...

Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by genetic mutations. But so far, attempts to use the technology to address ...

This figure illustrates the evolution of CRISPR technology from 1987 to 2019, presented in a horizontal timeline format and categorized into four generations, each denoted by a distinct color: The ...

Emerging gene-editing platforms are demonstrating that disease-causing mutations, aberrant gene expression, and even large-scale DNA insertions can be corrected without relying on error-prone DNA ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...